Hippocratic AI, a pioneering company on a mission to revolutionize healthcare through artificial intelligence, has successfully secured $141 million in its latest funding round. With a focused vision to create the first safety-oriented Large Language Model (LLM) specifically tailored for the healthcare sector, Hippocratic AI aims to enhance healthcare accessibility and significantly improve health outcomes across the globe. Founded by a team of esteemed professionals, including CEO Munjal Shah, alongside physicians and researchers from prestigious institutions such as El Camino Health, Johns Hopkins, and Stanford, the company is at the forefront of integrating advanced AI technology into healthcare. This impressive funding round brings the total investment in Hippocratic AI to $137 million, with support from high-caliber investors such as General Catalyst, Andreessen Horowitz, and Nvidia Venture Capital, among others. The funds will be strategically allocated to further develop and refine their LLM, enabling it to assist healthcare professionals in delivering better patient care and ensuring that medical knowledge is more accessible to everyone. This critical investment not only reflects investor confidence in Hippocratic AI’s unique approach but also highlights the growing recognition of AI’s potential to address some of the most pressing challenges in healthcare. By harnessing the power of artificial intelligence, Hippocratic AI is poised to make a lasting global impact on health, and we look forward to seeing their innovative solutions come to life. For more details on their groundbreaking work, visit www.HippocraticAI.com.
Hippocratic AI Secures $141 Million in Series B Funding to Revolutionize Healthcare AI
Recently funded · $141.0M Series bHealthcare
Get the full Hippocratic AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
